Miltown-600
Brand names,
Miltown-600
Analogs
Miltown-600
Brand Names Mixture
Miltown-600
Chemical_Formula
C20H23NS
Miltown-600
RX_link
No information avaliable
Miltown-600
fda sheet
Miltown-600
msds (material safety sheet)
Miltown-600
Synthesis Reference
No information avaliable
Miltown-600
Molecular Weight
309.469 g/mol
Miltown-600
Melting Point
< 25 oC
Miltown-600
H2O Solubility
Soluble as HCl salt
Miltown-600
State
Liquid
Miltown-600
LogP
5.7
Miltown-600
Dosage Forms
Tablets (oral, 1 mg)
Miltown-600
Indication
Used for the symptomatic treatment of parkinsonism.
Miltown-600
Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Miltown-600
Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Miltown-600
side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Miltown-600
Patient Information
Miltown-600
Organisms Affected
Humans and other mammals